Cargando…

Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM study

BACKGROUND: To determine if novel measures of cardiovascular health are associated with prevalence or progression of age-related macular degeneration (AMD). METHODS: Measures of the cardiovascular system: included intima media thickness (IMT), pulse wave velocity (PWV), systemic arterial compliance...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCarty, Catherine A, Dowrick, Adam, Cameron, James, McGrath, Barry, Robman, Luba D, Dimitrov, Peter, Tikellis, Gabriella, Nicolas, Caroline, McNeil, John, Guymer, Robyn
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627823/ https://www.ncbi.nlm.nih.gov/pubmed/19102747 http://dx.doi.org/10.1186/1471-2415-8-25

Ejemplares similares

Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)
por: Guymer, Robyn H, et al.
Publicado: (2008)

Proof of Concept, Randomized, Placebo-Controlled Study of the Effect of Simvastatin on the Course of Age-Related Macular Degeneration
por: Guymer, Robyn H., et al.
Publicado: (2013)

Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study
por: Robman, Liubov, et al.
Publicado: (2017)

Age Related Macular Degeneration and Total Hip Replacement Due to Osteoarthritis or Fracture: Melbourne Collaborative Cohort Study
por: Chong, Elaine W., et al.
Publicado: (2015)

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
por: Lad, Eleonora M., et al.
Publicado: (2023)

How Do Patients Respond to Genetic Testing for Age-related Macular Degeneration?
por: McCarty, Catherine A., et al.
Publicado: (2018)

Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly” (ASPREE)-AMD trial
por: Robman, Liubov D., et al.
Publicado: (2020)

Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
por: Hurley, Susan F, et al.
Publicado: (2008)

Comparison of Visual Function Tests in Intermediate Age-Related Macular Degeneration
por: Guymer, Robyn H., et al.
Publicado: (2021)

Cost-effectiveness of smoking cessation to prevent age-related macular degeneration
por: Hurley, Susan F, et al.
Publicado: (2008)

Subthreshold Nano-Second Laser Treatment and Age-Related Macular Degeneration
por: Cohn, Amy C., et al.
Publicado: (2021)

Presymptomatic Retinal Sensitivity Changes in Intermediate Age-Related Macular Degeneration Associated With New Retinal Fluid
por: Wightman, Antony J., et al.
Publicado: (2019)

Relationship Between Rod-Mediated Sensitivity, Low-Luminance Visual Acuity, and Night Vision Questionnaire in Age-Related Macular Degeneration
por: McGuinness, Myra B., et al.
Publicado: (2020)

Role of sleep-disordered breathing in age-related macular degeneration
por: Fang, Wendy Ying, et al.
Publicado: (2023)

Performance of a Smart Device over 12-Months for Home Monitoring of Patients with Intermediate Age-Related Macular Degeneration
por: Prea, Selwyn, et al.
Publicado: (2023)

New Technologies to Study Functional Genomics of Age-Related Macular Degeneration
por: Nguyen, Tu, et al.
Publicado: (2021)

Repeatability of Retinal Sensitivity Measurements Using a Medmont Dark-Adapted Chromatic Perimeter in Healthy and Age-Related Macular Degeneration Cases
por: Tan, Rose S., et al.
Publicado: (2018)

Exploring Reticular Pseudodrusen Extent and Impact on Mesopic Visual Sensitivity in Intermediate Age-Related Macular Degeneration
por: Kumar, Himeesh, et al.
Publicado: (2022)

A Tablet-Based Retinal Function Test in Neovascular Age-Related Macular Degeneration Eyes and At-Risk Fellow Eye
por: Ho, Chi Yun Doreen, et al.
Publicado: (2018)

Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration
por: Barthelmes, Daniel, et al.
Publicado: (2016)

Home Monitoring of Retinal Sensitivity on a Tablet Device in Intermediate Age-Related Macular Degeneration
por: Adams, Matthew, et al.
Publicado: (2018)

Open charm and beauty production in photon-photon collisions at L3
por: McNeil, R R
Publicado: (2000)

Properties of the Impact of Vision Impairment and Night Vision Questionnaires Among People With Intermediate Age-Related Macular Degeneration
por: McGuinness, Myra B., et al.
Publicado: (2019)

Comprehensive Analysis of Copy Number Variation of Genes at Chromosome 1 and 10 Loci Associated with Late Age Related Macular Degeneration
por: Cantsilieris, Stuart, et al.
Publicado: (2012)

Age-related macular degeneration.
por: McConnell, V., et al.
Publicado: (2005)

Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality—Should Patients with Elevated Levels Be Supplemented with Citrulline?
por: McCarty, Mark F.
Publicado: (2016)

The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study
por: Arnold, Jennifer J., et al.
Publicado: (2016)

Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration
por: Brilliant, Murray H., et al.
Publicado: (2015)

Learning Red Hat Enterprise Linux and Fedora
por: McCarty, Bill, et al.
Publicado: (2004)

Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration
por: Lewis Luján, Lidianys María, et al.
Publicado: (2022)

Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration
por: Yu, Yi, et al.
Publicado: (2011)

The Chronic Care for Wet Age Related Macular Degeneration (CHARMED) Study: A Randomized Controlled Trial
por: Markun, Stefan, et al.
Publicado: (2015)

Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration
por: Hageman, Gregory S, et al.
Publicado: (2011)

Nitration of tyrosines in complement factor H domains alters its immunological activity and mediates a pathogenic role in age related macular degeneration
por: Krilis, Matthew, et al.
Publicado: (2017)

Association Study of Mannose-Binding Lectin Levels and Genetic Variants in Lectin Pathway Proteins with Susceptibility to Age-Related Macular Degeneration: A Case-Control Study
por: Osthoff, Michael, et al.
Publicado: (2015)

Is interleukin-6 the link between low LDL cholesterol and increased non-cardiovascular mortality in the elderly?
por: DiNicolantonio, James J, et al.
Publicado: (2018)

The chronic care for age-related macular degeneration study (CHARMED): Study protocol for a randomized controlled trial
por: Frei, Anja, et al.
Publicado: (2011)

Levodopa Positively Affects Neovascular Age-Related Macular Degeneration
por: Figueroa, Anna G., et al.
Publicado: (2020)

Androgen therapy and atherosclerotic cardiovascular disease
por: McGrath, K-CY, et al.
Publicado: (2008)

TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration
por: Khanani, Arshad M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jqtcno5bilfv8j3k06gb1a51uk